[CAS NO. 175026-96-7]  NQDI-1

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [175026-96-7]

Catelog
SLK-S8289
Brand
Selleck
CAS
175026-96-7

DESCRIPTION [175026-96-7]

Overview

MDLMFCD03265970
Molecular Weight319.31
Molecular FormulaC19H13NO4
SMILESO=C(C1=C2C3=C(NC1=O)C=CC=C3C(C4=C2C=CC=C4)=O)OCC

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.1318 mL15.6588 mL31.3175 mL
5 mM0.6264 mL3.1318 mL6.2635 mL
10 mM0.3132 mL1.5659 mL3.1318 mL
50 mM0.0626 mL0.3132 mL0.6264 mL

Description

NQDI 1, an inhibitor of , attenuates acute ischemic renal injury by modulating oxidative stress and cell death.

Targets

ASK1 [3]
(Cell-free assay)
3 μM

In vivo

NQDI 1 inhibits the expression of ASK1 and downstream targets in the HI model. It also inhibits injury and apoptosis in the brain cortex. Intracerebroventricularly injection of NQDI 1 after neonatal rats brain HI significantly attenuates acute HI cerebral injury by inhibiting cell apoptosis. The treatment of NQDI-1 markedly inhibits the expression of ASK1 following HI in the perinatal rat, accompanied by a decrease of p-JNK, p-c-Jun, p53 and caspase 3, which were the downstream targets of ASK1.